Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 0C7, Canada.
Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya 464-8601, Japan.
Int J Mol Sci. 2024 Sep 25;25(19):10306. doi: 10.3390/ijms251910306.
Transglutaminase enzymes catalyze Ca- and thiol-dependent posttranslational modifications of glutamine-residues that include esterification, hydrolysis and transamidation, which results in covalent protein-protein crosslinking. Among the eight transglutaminase family members in mammals, transglutaminase 1 (TG1) plays a crucial role in skin barrier formation via crosslinking and insolubilizing proteins in keratinocytes. Despite this established function in skin, novel functions have begun merging in normal tissue homeostasis as well as in pathologies. This review summarizes our current understanding of the structure, activation, expression and activity patterns of TG1 and discusses its putative novel role in other tissues, such as in vascular integrity, and in diseases, such as cancer and fibrosis.
转谷氨酰胺酶通过催化谷氨酸残基的 Ca2+和巯基依赖的翻译后修饰,包括酯化、水解和转酰胺作用,导致蛋白质-蛋白质的共价交联。在哺乳动物的 8 种转谷氨酰胺酶家族成员中,转谷氨酰胺酶 1(TG1)通过交联和稳定角质形成细胞中的蛋白质,在皮肤屏障形成中发挥关键作用。尽管在皮肤中有这种已确立的功能,但在正常组织稳态以及病理学中,新的功能开始出现。本文总结了我们目前对 TG1 的结构、激活、表达和活性模式的理解,并讨论了其在其他组织(如血管完整性)和疾病(如癌症和纤维化)中的潜在新作用。